Marcos meets with execs of Asia’s largest dialysis care network

President Ferdinand R. Marcos Jr. meets with NephroPlus Group CEO Rohit Singh and other officials of Asia’s ‘largest dialysis care network’ on Thursday, August 7, 2025 as part of his state visit to India. — Photo from Presidential Communications Office

MANILA, Philippines — President Ferdinand Marcos Jr. met with Asia’s “largest dialysis network” to explore deeper collaboration in advancing universal healthcare in the country, the Presidential Communications Office (PCO) said on Friday.

The meeting was part of Marcos’ agenda on Thursday in Bangalore — the final leg of his five-day state visit to India.

READ: PhilHealth raises dialysis benefits, but private labs to cost more

In a social media post, the PCO said Marcos met with officials from NephroPlus to reaffirm the commitment of both the Philippines and India to expanding access to high-quality, patient-centered renal care.

“They decided to have a meeting with us, especially now that our rates are P6,350 (from P2,500) per session for each dialysis patient. So they are seeing that it’s now going to be very profitable,” said Health Secretary Teodoro Herbosa in a briefing interview.

“That’s good because then the government does not have to build many dialysis centers; all it does is make sure that the private sector does provide quality dialysis for Filipinos,” he also said.

NephroPlus is considered Asia’s most extensive dialysis care network, operating in India, Nepal, the Philippines, and Uzbekistan, with more than 400 clinics across the continent.

READ: Patients raise alarm over closure of hemodialysis center in Negros town

According to the National Kidney and Transplant Institute, the number of Filipinos undergoing dialysis treatment in 2024 was recorded at 64,845 — 22 percent higher than the 53,296 logged in 2023.

Meanwhile, as of March 2025, the Philippine Renal Disease Registry of the Department of Health reported that hypertensive nephrosclerosis accounted for 33.07 percent of kidney disease cases in the country.

This was followed by diabetic nephropathy at 30.04 percent and chronic glomerulonephritis at 12.20 percent. /das